Lang James Paul bought HALO
January 2, 2026 · Form 4 insider transaction
Lang James Paul bought 1,342 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,342
Price
$0.00
Total value
N/A
InsiderLang James Paul
Role—
SecurityOption to Purchase Common Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after1,342
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a stock options granted under the Issuer director compensation program. This grant will vest in full on the date of the Issuer 2026 annual meeting of stockholders.